A role for uric acid in the progression of renal disease

Journal of the American Society of Nephrology

Volumn 13, Issue 12, 2002, Pages 2888-2897

  Kang, Duk Hee ^a,b,c,e   Nakagawa, Takahiko ^a   Feng, Lili ^a   Watanabe, Susumu ^a   Han, Lin ^a   Mazzali, Marilda ^a   Truong, Luan ^a   Harris, Raymond ^d   Johnson, Richard J ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^c Ewha Womans University School of Medicine   (South Korea)

^d VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e Ewha Womans University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOPURINOL; BENZIODARONE; CREATININE; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITOR; KIDNEY RENIN; OXONIC ACID; THROMBOXANE A2 RECEPTOR BLOCKING AGENT; URIC ACID; URICOSURIC AGENT; XANTHINE OXIDASE INHIBITOR; ISOENZYME; PROSTAGLANDIN SYNTHASE;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD PRESSURE; CELL PROLIFERATION; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DRUG EFFECT; GLOMERULOSCLEROSIS; HISTOPATHOLOGY; HYPERURICEMIA; KIDNEY ARTERY; KIDNEY DISEASE; KIDNEY FIBROSIS; KIDNEY FUNCTION; KIDNEY HYPERTROPHY; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEINURIA; RAT; VASCULAR DISEASE; VASCULAR SMOOTH MUSCLE; ANIMAL; CELL DIVISION; CYTOLOGY; DISEASE COURSE; ENZYMOLOGY; HYPERTENSION; HYPERTROPHY; KIDNEY; KIDNEY CIRCULATION; METABOLISM; METHODOLOGY; NEPHRECTOMY; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SPRAGUE DAWLEY RAT;

ANIMALS; BLOOD PRESSURE; CELL DIVISION; CYCLOOXYGENASE 2; DISEASE PROGRESSION; HYPERTENSION; HYPERTROPHY; HYPERURICEMIA; ISOENZYMES; KIDNEY; KIDNEY DISEASES; MALE; MUSCLE, SMOOTH, VASCULAR; NEPHRECTOMY; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; RATS; RATS, SPRAGUE-DAWLEY; RENAL CIRCULATION; RENIN-ANGIOTENSIN SYSTEM; URIC ACID; VASCULAR DISEASES;

EID: 0036892614     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ASN.0000034910.58454.FD     Document Type: Article

References (36)

1. Berger L, Yü T: Renal function in gout: IV: An analysis of 524 gouty subjects including long-term follow-up studies. Am J Med 59: 605-613, 1975
2. Talbott JH, Terplan KL: The kidney in gout. Medicine 39: 405-467, 1960
3. Gonick HC, Rubini MD, Gleason IO, Sommers SC: The renal lesion in gout. Ann Int Med 62: 667-674, 1965
4. Beck L: Requiem for gouty nephropathy. Kidney Int 30: 280-287, 1986
5. Nickeleit V, Mihatsch MJ: Uric acid nephropathy and end stage renal disease: Review of a non-disease. Nephrol Dial Transpl 12: 1832-1838, 1997
6. Johnson RJ, Kivlighn SD, Kim Y-G, Suga S, Fogo A: Reappraisal of the pathogenesis and consequences of hyperuricemia in hypertension, cardiovascular disease, and renal disease. Am J Kid Dis 33: 225-234, 1999
7. Rosenfeld JB: Effect of long-term allopurinol administration on serial GFR in normotensive and hypertensive hyperuricemic subjects. Adv Exp Med Biol 41B: 581-596, 1974
8. Perez-Ruiz F, Calabozo M, Fernandez-Lopez MJ, Herrero-Beites A, Ruiz-Lucea E, Garcia-Erasukin G, Duruelo J, Alonso-Ruiz A: Treatment of chronic gout in patients with renal function impairment. An open, randomized actively controlled study. J Clin Rheumatol 5: 49-55, 1999
9. Mazzali M, Hughes J, Kim YG, Jefferson JA, Kang D-H, Gordon KL, Lan HY, Kivlighn S, Johnson RJ: Elevated uric acid increases blood pressure in the rat by a novel crystal-independent mechanism. Hypertension 38: 1101-1106, 2001
10. Mazzali M, Kanellis J, Han L, Feng L, Chen Q, Kang DH, Watanabe S, Nakagawa T, Lan HY, Johnson RJ: Hyperuricemia induces a primary arteriolopathy in rats by a blood pressure-independent mechanism. Am J Physiol Renal Physiol 282:F991-F997, 2002
11. Mazzali M, Kim Y-G, Suga S, Gordon KL, Kang D-H, Jeferson JA, Hughes J, Kivlighn SD, Lan HY, Johnson RJ: Hyperuricemia exacerbates chronic cyclosporine nephropathy. Transplantation 71:900-905, 2001
12. Vaziri ND, Freel RK, Hatch M: Effect of chronic experimental renal insufficiency on urate metabolism. J Am Soc Nephrol 6: 1313-7, 1995
13. Harris RC, Breyer MD: Physiological regulation of cyclooxygenase-2 in the kidney. Am J Physiol Renal Physiol 281:F1-F11, 2001
14. Wang J-L, Cheng H-F, Shappell S, Harris RC: A selective cycloxygenase-2 inhibitor decreases proteinuria and retards progressive renal injury in rats. Kidney Int 57: 2334-2342, 2000
15. Bunag RD, Buttefield J: Tail-cuff blood pressure measurement without external preheating in awake rats. Hypertension 4: 898- 903, 1982
16. Henry RJ, Sobel C, Kim J: A modified carbonate phosphotungstate method for the determination of uric acid and comparison with the spectrophotometric uricase method. Am J Clin Pathol 28:152-160, 1957
17. Kang DH, Joly AH, Oh SW, Hugo C, Kerjaschki D, Gordon KL, Mazzali M, Jefferson JA, Hughes J, Madsen KM, Schreiner GF, Johnson RJ: Impaired angiogenesis in the remnant kidney model (I): Potential role of vascular endothelial growth factor and thrombospondin-1. J Am Soc Nephrol 12: 1434-1447, 2001
18. Elger M, Sakai T, Kritz W: The vascular pole of the renal glomerulus of rat. Adv Ana Embryol Cell Biol 139: 1-98, 1998
19. Eng E, Veniant M, Floege J, Fingerle J, Alpers CE, Menard J, Clozel JP, Johnson RJ: Renal proliferation and phenotypic changes in rats with two-kidney, one-clip Goldblatt hypertension. Am J Hypertens 7: 177-185, 1994
20. Feng L, Sun W, Xia Y, Tang W, Chanmugam P, Soyoola E, Wilson CB, Hwang D: Cloning two isoforms of rat cyclooxygenase: Differential regulation of their expression. Arch Biochem Biophys 307: 361-368, 1993
21. Xia Y, Pauza ME, Feng L, Lo D: RelB regulation of chemokine expression modulates local inflammation. Am J Pathol 151: 375-387, 1997
22. Couser WG, Pippin JW, Shankland SJ: Complement (C5b-9) induces DNA synthesis in rat mesangial cells in vitro. Kidney Int 59:905-912, 2001
23. Kang DH, Hughes J, Mazzali M, Schreiner GF, Johnson RJ: Impaired angiogenesis in the remnant kidney model (II): VEGF administration reduces renal fibrosis and stabilizes renal function. J Am Soc Nephrol 12: 1448-1457, 2001
24. Young W, Mahboubi K, Haider A, Li I, Ferreri NR: Cyclooxygenase-2 is required for tumor necrosis factor-alpha- and angiotensin II-mediated proliferation of vascular smooth muscle cells. Circ Res 86: 906-914, 2000
25. Hebert LA, Wilmer WA, Falkenhain ME, Ladson-Wofford ST, Nahman NS, Rovin BH: Renoprotection: One or many therapies? Kidney Int 59: 1211-1226, 2001
26. Syrjänen J, Mustonen J, Pasternak A: Hypertriglyceridemia and hyperuricemia are risk factors for progression of IgA nephropathy. Nephrol Dial Transpl 15: 34-42, 2000
27. Ohno I, Hosoya T, Gomi H, Ichida K, Okabe H, Hikita M: Serum uric acid and renal prognosis in IgA nephropathy. Nephron 87: 333-339, 2001
28. Iseki K, Oshiro S, Tozawa M, Iseki C, Ikemiya Y, Takishita S: Significance of hyperuricemia on the early detection of renal failure in a cohort of screened subjects. Hypertens Res 24: 691-697, 2001
29. Saito I, Saruta T, Kondo K, Nakamura R, Oguro T, Yamagami K, Ozawa Y, Kato E: Serum uric acid and the renin-angiotensin system in hypertension. J Am Geriatrics Soc 26: 241-247, 1978
30. Fine LG, Orphanides C, Norman JT: Progressive renal disease: The chronic hypoxia hypothesis. Kidney Int 65: S74-S78, 1998
31. Goldblatt H: The renal origin of hypertension. Physiol Rev 27: 120-165, 1947
32. Johnson RJ, Herrera-Acosta J, Schreiner GF, Rodriguez-Iturbe B: Subtle acquired renal injury as a mechanism of salt-sensitive hypertension. N Engl J Med, 346: 913-923, 2002
33. Rao GN, Corson MA, Berk BC: Uric acid stimulates vascular smooth muscle cell proliferation by increasing platelet derived growth factor A-chain expression. J Biol Chem 266: 8604-8608, 1991
34. Theuer J, Dechend R, Muller DN, Park JK, Fiebeler A, Barta P, Ganten D, Haller H, Dietz R, Luft FC: Angiotensin II induced inflammation in the kidney and in the heart of double transgenic rats. BMC Cardiovasc Disord 2: 3-14, 2002
35. Henrion D, Dechaux E, Dowell FJ, Maclour J, Samuel JL, Levy BI, Michel JB: Alteration of flow-induced dilatation in mesenteric resistance arteries of L-NAME treated rats and its partial association with induction of cyclo-oxygenase-2. Br J Pharmacol 121: 83-90, 1997
36. Hernandez J, Astudillo H, Escalante B: Angiotensin II stimulates cyclooxygenase-2 mRNA expression in renal tissue from rats with renal failure. Am J Physiol Renal Physiol 282: F592-F598, 2002